Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ALLY Adaptive Cataract Treatment System

K-Number: K220259 · 2022-06-09

ApplicantLensar, Inc.
Decision Date2022-06-09
Product CodeOOE
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

ALLY Adaptive Cataract Treatment System is the device name listed in this FDA 510(k) record. The listed applicant is Lensar, Inc.. It received FDA 510(k) clearance on 2022-06-09 under 510(k) number K220259. The device is classified under product code OOE. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ALLY Adaptive Cataract Treatment System?

ALLY Adaptive Cataract Treatment System is a medical device that received FDA 510(k) clearance on 2022-06-09. The listed applicant is Lensar, Inc.. The 510(k) number is K220259.

When did ALLY Adaptive Cataract Treatment System receive FDA 510(k) clearance?

ALLY Adaptive Cataract Treatment System received FDA 510(k) clearance on 2022-06-09, under 510(k) number K220259.

Who is the listed applicant for ALLY Adaptive Cataract Treatment System?

The FDA 510(k) record lists Lensar, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ALLY Adaptive Cataract Treatment System?

The FDA product code for ALLY Adaptive Cataract Treatment System is OOE.

Other records listing Lensar, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: OOE)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.